Lexicon Pharmaceuticals NASDAQ: LXRX reported a wider second-quarter loss as revenue declined sharpl

Lexicon Pharmaceuticals, Inc. (LXRX) Q2 2026 Earnings Call Transcript

Lexicon Pharmaceuticals (LXRX) came out with a quarterly loss of $0.06 per share in line with the Za

Enrollment complete in Phase 3 SONATA-HCM study; top-line data expected Q1 2027  NDA resubmission ac

THE WOODLANDS, Texas, July 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)

The study substantially exceeded its enrollment target of 500 patients across more than 130 sites in

Study substantially exceeded enrollment target of 500 patients Topline results anticipated in Q1 202

Lexicon advances sotagliflozin into new indications while its obesity and pain programs progress, se

One company posts rapid revenue growth but remains unprofitable, while the other boasts global scale

Presentations highlight consistent A1c reductions with sotagliflozin in type 1 diabetes and pharmaco

THE WOODLANDS, Texas, May 28, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)

THE WOODLANDS, Texas, May 12, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)

Lexicon Pharmaceuticals NASDAQ: LXRX executives highlighted progress across late-stage regulatory pr

Lexicon Pharmaceuticals, Inc. (LXRX) Q1 2026 Earnings Call Transcript

Lexicon Pharmaceuticals (LXRX) reported break-even quarterly earnings per share versus the Zacks Con

SONATA-HCM anticipated to be fully enrolled mid-2026  Resubmission of NDA for ZYNQUISTA ® in type 1

THE WOODLANDS, Texas, May 04, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX)

THE WOODLANDS, Texas, April 30, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX

Oral presentation highlights additional data from PROGRESS Phase 2b study of pilavapadin supporting

Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX - Get Free Report) shares crossed above its 200-day movi

U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market.

Lexicon Pharmaceuticals stock jumps as NVO launches phase I study of oral obesity candidate LX9851,

U.S. stock futures were higher this morning, with the Dow futures gaining more than 100 points on Mo

Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its

Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after fal

  On Tuesday, 647 companies set new 52-week lows.

  During the session on Thursday, 461 stocks hit new 52-week lows.

  During Tuesday's session, 275 companies made new 52-week lows.

  On Thursday, 283 companies set new 52-week lows.

The Dow Jones closed lower by over 400 points on Monday. When insiders purchase or sell shares, it i

Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings

Companies Reporting Before The Bell • argenx (NASDAQ:ARGX) is expected to report quarterly loss at

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

Gainers Getty Images Holdings, Inc. (NYSE: GETY) rose 104.5% to $21.47 in pre-market trading.

Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining

Gainers JAKKS Pacific, Inc. (NASDAQ: JAKK) rose 34.7% to $23.01 in pre-market trading after the c